X

Celestial Biolabs Ltd Stock Analysis

Small Cap
Evaluated by 407 users | BSE: 532871 | NSE: CELESTIAL |
Pharmaceuticals & Drugs
Celestial Labs Limited was incorporated as a Private Limited Company on November 19, 1997 as Celestial Technologies Private Limited. The company was later converted into a Public Limited Company under the name Celestial Technologies Limited'on December 6, 1999 and has been subsequently renamed...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Capital Employed 8.72%3.68%3.18%1.54%1.28%2.41%4.16%2.96%3.17%3.18%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 19.321.525.220.621.223.527.532.938.742.8
Y-o-Y Gr. Rt.-11.8%17.1%-18.4%2.8%11.1%16.8%19.7%17.7%10.7%
Adjusted EPS (Rs.) 4.741.981.660.630.490.490.71.021.481.53
Y-o-Y Gr. Rt.--58.2%-16.2%-62.1%-22.2%0%42.9%45.7%45.1%3.4%
Book Value per Share (Rs.) 47.8349.6353.1653.7954.2849.3343.5543.9643.7645.29
Adjusted Net Profit 5.32.32.40.90.70.81.32.13.33.5
Net Op. Cash Flow (Rs. Cr.) 3.62.913.23.23.35.8813.43.3
Debt to Cash Flow from Ops 0.211.9510.633.924.725.641.931.030.622.82
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Celestial Biolabs Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 9.3%15.1%16%10.7%
Adjusted EPS -11.8%25.6%29.8%3.4%
Book Value per Share -0.6-3.61.33.5
Share Price -22.8% -37% -46.5% 20.3%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Equity (%) 8.663.523.31.170.91.021.512.283.433.44
Operating Profit Margin (%) 33.3314.7524.1220.6826.932.9845.326.0418.127.63
Net Profit Margin (%) 27.5810.859.64.443.353.594.726.338.628.07
Debt to Equity 0.010.10.140.160.190.220.140.090.080.09
Working Capital Days 47072195473551587583517308206
Cash Conversion Cycle 1126285163178207240234171169
Entity Percentage Holding
Promoters 26.07%
Non-Institutions 73.93%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Celestial Biolabs Ltd's performance infers:

Celestial Biolabs Ltd earnings have grown by 25.6%, whereas share price has depreciated -37% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Celestial Biolabs Ltd share prices over the last 10 years. Here is what we found out:

Celestial Biolabs Ltd share price has depreciated -23.3% annually over the past ten years.

Celestial Labs Limited was incorporated as a Private Limited Company on November 19, 1997 as Celestial Technologies Private Limited. The company was later converted into a Public Limited Company under the name Celestial Technologies Limited'on December 6, 1999 and has been subsequently renamed as Celestial Labs Limited effective from February 13, 2004.

Celestial Labs ( CLL ) has been supporting Pharma, Bio-pharma and Biotech manufacturing with customized ITsolutions and contract research.

Celestial Labs Limited was incorporated as a Private Limited Company on November 19, 1997 as Celestial Technologies Private Limited. The company was later converted into a Public Limited Company under the name Celestial Technologies Limited'on December 6, 1999 and has been subsequently renamed as Celestial Labs Limited effective from February 13, 2004.

Celestial Labs ( CLL ) has been supporting Pharma, Bio-pharma and Biotech manufacturing with customized ITsolutions and contract research. CLL also involved in the R&D, commercial production and marketing of enzymes, nutraceuticals.Celestial Labs is setting up a biotechnology facility in Genome Valley at Hyderabad, India to manufacture its own drug molecules, industrial enzymes and to contract research activities.

Celestial Labs Ltd (CLL) is an ISO 9001-2001 certified company with a decade of experience in Insilico Drug Discovery and Development, and contract research services.Celestial Labs is recognized by DSIR (Government of India) for its R&D endeavors in the Insilco Drug Discovery software development. Celestial has been providing customized solutions and services in Bio-IT as well as research services over a decade.

The business plan of Celestial Labs is essentially based on the production and supply of the biotechnological products which have very significant industrial implications, especially in both Pharma and Bio-pharmaceutical sectors. The plan is envisaged after a thorough ground-work in terms of building up of a technology base through stake holders and collaborators, further supported by market analysis and import-export imperatives. Celestial's ambitious goals earmarked with well-worked road map, strategic implementation and management tools are well supported by its competent and experienced personnel to effectively carry out the scientific, engineering, finance and management functions of its project activities.

Products and services offered by the company:Products:

  • Informatics
  • Enzymes
  • Neutraceuticals
  • Peptides

Services:

  • Drug Discovery Services
  • Bio Technology
  • Bio IT Services

Achievements/ recognition :

  • ISO 9001 – 2001 certified company
  • Recognized by DSIR (Government of India) for its R&D endeavors in the Insilco Drug Discovery software development
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback